When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Last reviewed: 19 Mar 2025
Last updated: 23 Aug 2023

Summary

Definition

History and exam

Key diagnostic factors

  • presence of risk factors
  • fever/sweats
  • cough
  • septic shock
  • regional lymphadenitis/parotitis
  • non-healing skin sore/ulcer or abscess
  • bacteraemia without evident clinical focus
  • lower motor neuron cranial nerve palsies (especially cranial nerves VII and VIII)
  • flaccid paralysis

Other diagnostic factors

  • shortness of breath
  • abdominal pain/diarrhoea
  • dysuria
  • urinary retention
  • other signs of organ abscess
  • altered conscious state
  • arthritis/osteomyelitis
  • mycotic pseudo-aneurysms

Risk factors

  • travel to endemic area
  • occupational/recreational environmental exposure
  • diabetes
  • hazardous alcohol use
  • chronic renal or liver disease
  • malignancy and immunosuppressive therapy
  • thalassaemia
  • cystic fibrosis and other chronic lung disease
  • bioterrorism

Diagnostic investigations

1st investigations to order

  • blood culture
  • sputum culture
  • urine culture
  • culture of pus/swab from skin lesion, abscess, lymphadenitis, drained internal abscess (e.g., liver abscess)
  • chest x-ray
  • computer tomography (CT) abdomen and pelvis ± CT chest
  • abdominal/pelvis ultrasound

Investigations to consider

  • throat swab in/on Ashdown's selective broth/agar
  • rectal swab in/on Ashdown's selective broth/agar
  • cerebrospinal fluid (CSF) culture
  • CSF microscopy, protein and glucose
  • polymerase chain reaction (PCR)

Emerging tests

  • rapid antigen detection test

Treatment algorithm

Contributors

Authors

Bart J. Currie, MBBS, FRACP, FAFPHM, DTM+H

Professor in Medicine

Northern Territory Medical Program

Royal Darwin Hospital

Head of Tropical and Emerging Infectious Diseases

Menzies School of Health Research

Charles Darwin University

Darwin

Australia

Disclosures

BJC is the author of several references cited in this topic.

David A.B. Dance, MB, ChB, MSc, FRCPath
David A.B. Dance

Senior Clinical Research Fellow/Consultant Microbiologist

Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit

Vientiane

Laos

Centre for Tropical Medicine and Global Health

University of Oxford

Oxford

Honorary Professor

Faculty of Infectious and Tropical Diseases

London School of Hygiene and Tropical Medicine

London

UK

Disclosures

DABD is the author of several references cited in this topic. DABD has acted as a consultant to InBios International Inc. (in relation to the development of rapid diagnostic tests for melioidosis), and to MerLion Pharmaceuticals and Venatorx Pharmaceuticals (in relation to the development of novel therapies for melioidosis).

Peer reviewers

Robert Norton, MBBCh (Hons), MRCP (UK), FRCPA, MD

Director of Microbiology

Townsville Hospital

Townsville

Australia

Disclosures

RN declares that he has no competing interests.

Ploenchan Chetchotisakd, MD

Professor of Medicine

Faculty of Medicine

Khon Kaen University

Khon Kaen

Thailand

Disclosures

PC declares that he has no competing interests.

Use of this content is subject to our disclaimer